NCT05565417 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT05565417
Title	Study of the Monoclonal Antibody IMT-009 in Patients with Advanced Solid Tumors or Lymphomas
Recruitment	Active, not recruiting
Gender	both
Phase	Phase Ib/II
Variant Requirements	Yes
Sponsors	Immunitas Therapeutics
Indications	Burkitt lymphoma colorectal cancer small intestine carcinoma estrogen-receptor positive breast cancer progesterone-receptor positive breast cancer skin squamous cell carcinoma head and neck squamous cell carcinoma esophageal cancer triple-receptor negative breast cancer Hodgkin's lymphoma diffuse large B-cell lymphoma follicular lymphoma adult T-cell leukemia/lymphoma lung non-small cell carcinoma
Therapies	Fruquintinib + IMT-009 IMT-009
Age Groups:	adult \| senior
Covered Countries	USA

Facility	City	State	Zip	Country	Details
Site 9618	Tucson	Arizona	85711	United States	Details
Site 5000	Denver	Colorado	80218	United States	Details
Site 4100	Orlando	Florida	32827	United States	Details
Site 4060	Sarasota	Florida	34232	United States	Details
Site 4500	Oklahoma City	Oklahoma	73104	United States	Details
Site 9280	Portland	Oregon	97239	United States	Details
Site 3000	Nashville	Tennessee	37203	United States	Details
Site 9384	Austin	Texas	78705	United States	Details
Site 9112	Fairfax	Virginia	22031	United States	Details

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field

NCT05565417Clinical Trial Detail